Shilpa Medicare to sell biological unit to subsidiary

25 Feb 2020 Evaluate

Shilpa Medicare has received approval from its board for the sale of biological unit by way of slump sale to Shilpa Biologicals, a wholly owned subsidiary of the company subject to the approval of shareholders. The biological unit proposed to be sold is under construction/installation stage and not yet commenced commercial operations.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine  Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

278.55 -11.40 (-3.93%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×